Amstelveen, Netherlands

Dennis Verzijl

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 8.5

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Utrecht, NL (2022)
  • Amstelveen, NL (2019 - 2024)

Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dennis Verzijl

Introduction

Dennis Verzijl is a prominent inventor based in Amstelveen, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 10 patents to his name, Verzijl's work has the potential to impact cancer therapy and diagnostic procedures.

Latest Patents

Among his latest patents, one invention focuses on antibodies capable of binding to human OX40. This invention includes variants that have a modified Fc region, which enhances the Fc-Fc interaction while reducing the Fc effector functions of the antibody. Additionally, he has developed pharmaceutical compositions that utilize these antibodies for therapeutic and diagnostic applications, especially in cancer therapy. Another notable patent involves antibodies binding to 5T4, including bispecific antibodies that target both 5T4 and CD3. This invention also provides pharmaceutical compositions for therapeutic and diagnostic uses in cancer treatment.

Career Highlights

Throughout his career, Dennis Verzijl has worked with leading companies in the biotechnology sector, including Genmab and BioNTech SE. His experience in these organizations has allowed him to contribute to groundbreaking research and development in antibody therapies.

Collaborations

Verzijl has collaborated with notable professionals in the field, including David Satijn and Edward Norbert Van Den Brink. These collaborations have further enhanced the impact of his inventions and research.

Conclusion

Dennis Verzijl's innovative work in the field of biotechnology, particularly in the development of therapeutic antibodies, showcases his significant contributions to cancer therapy. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…